Literature DB >> 34112125

Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis.

Hongjian Wu1, Wubing Jiang1, Guanghua Ji2, Rong Xu1, Gaobo Zhou1, Hongyuan Yu3.   

Abstract

BACKGROUND: Bladder cancer (BC) is the second most frequent malignancy of the urinary system. The aim of this study was to identify key microRNAs (miRNAs) and hub genes associated with BC as well as analyse their targeted relationships.
METHODS: According to the microRNA dataset GSE112264 and gene microarray dataset GSE52519, differentially expressed microRNAs (DEMs) and differentially expressed genes (DEGs) were obtained using the R limma software package. The FunRich software database was used to predict the miRNA-targeted genes. The overlapping common genes (OCGs) between miRNA-targeted genes and DEGs were screened to construct the PPI network. Then, gene ontology (GO) analysis was performed through the "cluster Profiler" and "org.Hs.eg.db" R packages. The differential expression analysis and hierarchical clustering of these hub genes were analysed through the GEPIA and UCSC Cancer Genomics Browser databases, respectively. KEGG pathway enrichment analyses of hub genes were performed through gene set enrichment analysis (GSEA).
RESULTS: A total of 12 DEMs and 10 hub genes were identified. Differential expression analysis of the hub genes using the GEPIA database was consistent with the results for the UCSC Cancer Genomics Browser database. The results indicated that these hub genes were oncogenes, but VCL, TPM2, and TPM1 were tumour suppressor genes. The GSEA also showed that hub genes were most enriched in those pathways that were closely associated with tumour proliferation and apoptosis.
CONCLUSIONS: In this study, we built a miRNA-mRNA regulatory targeted network, which explores an understanding of the pathogenesis of cancer development and provides key evidence for novel targeted treatments for BC.

Entities:  

Keywords:  Bladder cancer; Hub genes; MiRNA-mRNA network; MiRNAs

Year:  2021        PMID: 34112125     DOI: 10.1186/s12894-021-00857-w

Source DB:  PubMed          Journal:  BMC Urol        ISSN: 1471-2490            Impact factor:   2.264


  37 in total

Review 1.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

2.  Laboratory controls--an FDA investigator's viewpoint.

Authors:  H L Avallone
Journal:  J Parenter Sci Technol       Date:  1986 Sep-Oct

3.  MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.

Authors:  Jin-Rong Wang; Bin Liu; Lei Zhou; Yue-Xin Huang
Journal:  Cancer Biomark       Date:  2019       Impact factor: 4.388

4.  MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.

Authors:  Guoliang Hou; Wenfeng Xu; Yabin Jin; Jialing Wu; Yingming Pan; Fangjian Zhou
Journal:  Biochem Biophys Res Commun       Date:  2019-09-20       Impact factor: 3.575

5.  An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy.

Authors:  Kosar Babaei; Shima Shams; Arman Keymoradzadeh; Sogand Vahidi; Parisa Hamami; Roya Khaksar; Seyedeh Elham Norollahi; Ali Akbar Samadani
Journal:  Life Sci       Date:  2019-11-18       Impact factor: 5.037

Review 6.  microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer.

Authors:  Hao Yu; Yinhui Lu; Zhaofa Li; Qizhao Wang
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

Review 7.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

8.  A novel community driven software for functional enrichment analysis of extracellular vesicles data.

Authors:  Mohashin Pathan; Shivakumar Keerthikumar; David Chisanga; Riccardo Alessandro; Ching-Seng Ang; Philip Askenase; Arsen O Batagov; Alberto Benito-Martin; Giovanni Camussi; Aled Clayton; Federica Collino; Dolores Di Vizio; Juan Manuel Falcon-Perez; Pedro Fonseca; Pamali Fonseka; Simona Fontana; Yong Song Gho; An Hendrix; Esther Nolte-'t Hoen; Nunzio Iraci; Kenneth Kastaniegaard; Thomas Kislinger; Joanna Kowal; Igor V Kurochkin; Tommaso Leonardi; Yaxuan Liang; Alicia Llorente; Taral R Lunavat; Sayantan Maji; Francesca Monteleone; Anders Øverbye; Theocharis Panaretakis; Tushar Patel; Héctor Peinado; Stefano Pluchino; Simona Principe; Goran Ronquist; Felix Royo; Susmita Sahoo; Cristiana Spinelli; Allan Stensballe; Clotilde Théry; Martijn J C van Herwijnen; Marca Wauben; Joanne L Welton; Kening Zhao; Suresh Mathivanan
Journal:  J Extracell Vesicles       Date:  2017-05-26

Review 9.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

Review 10.  Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis.

Authors:  Piotr Kutwin; Tomasz Konecki; Edyta Marta Borkowska; Magdalena Traczyk-Borszyńska; Zbigniew Jabłonowski
Journal:  Cent European J Urol       Date:  2018-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.